Founder and CEO, Mark Rosenbloom, MD, MBA joins PEPID Pulse’s Implementing Precision Medicine live broadcast series at HIMSS 2019. Dr. Rosenbloom’s talk, “Implementing Precision Medicine in the Clinical Setting: Challenges and Rewards” expounds on:
- Pharmacogenomics’ present utilization and projected growth,
- The short- and long-term challenges and merits of PGx adoption, and
- How actionable point-of-care resources such as PEPID’s PGx can significantly improve clinician workflow while improving patient outcomes.
Check back soon for a detailed transcription of this broadcast.
For 25 years, PEPID has been a leading global developer of clinical and drug information resources and mobile applications for healthcare providers and institutions. Their trusted, validated content and intuitive workflow provide clinicians peer-reviewed support for diagnosis and treatment at the patient-point-of-care. It’s accessed individually or integrated into any healthcare system.
To find out more, go to www.pepid.com
Questions or comments, e-mail Anna Tan at email@example.com.